Navigation Links
Judith Quinlan Joins Cytel as Vice President, Adaptive Trials
Date:5/14/2008

Recognized clinical trial innovations advocate to lead expansion of Cytel's

adaptive trial design and implementation business

CAMBRIDGE, Mass., May 14 /PRNewswire/ -- Cytel Inc., a leading provider of clinical trial design services and specialized statistical software, today announced the appointment of Judith Quinlan as Vice President, Adaptive Trials.

Judith Quinlan brings over twenty years of statistical experience to the Cytel team. Prior to joining Cytel Judith spent 10 years with GSK, most recently as Statistics Director for biopharmaceuticals, and previously as Statistics Director for Neurology and GI. Throughout the last seven years she's focused on bridging the gap between new clinical research concepts and the challenging practicalities of conducting complex trials.

"Judith Quinlan has been a persistent and persuasive proponent of adaptive clinical trials both at GSK, and through her work with the PhRMA Working Group on Adaptive Designs (ADWG). This is helping pave the way toward the wide acceptance of innovative, flexible clinical study approaches. Judith combines clinical theory and practice with a strategic business perspective on Clinical Development Programs. We are very pleased, indeed, to have Judith on board," said Cytel's CEO, Ranganath Nayak.

In her new role, Judith Quinlan will guide Cytel's adaptive trial design and implementation offerings, leveraging her previous successes in managing cross-functional clinical research teams to drive more productive planning and implementation of early stage and confirmatory trials. In addition to overseeing Cytel's flourishing adaptive study efforts, Judith will continue her advocacy and education work as an active member of the PhRMA Working Group on Adaptive Designs.

A popular speaker on adaptive trial design and operations, Judith Quinlan has co-authored articles on numerous clinical research-related topics. Judith has published in such prestigious journals as Pharmacotherapy and Computational Statistics, and she co-authored with Wyeth's Mike Krams the influential PhRMA group's paper on "Implementing Adaptive Designs: Logistical and Operational Issues."

About Cytel

Cytel Inc. is a leading provider of clinical trial design services and specialized statistical software for the biopharmaceutical, medical device, academic, and government research markets. Cytel's East(R) system is used by biostatisticians and clinicians at hundreds of companies, throughout academia and by regulators to design, simulate and monitor group sequential and adaptive clinical trials. Cytel provides trial sponsors with innovative tools, training, and consultation to increase process efficiencies and reduce development costs.


'/>"/>
SOURCE Cytel Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. General Wesley Clark Joins Immtech as Consulting Strategic Advisor
2. Actress and New Mom Keri Russell Joins PKIDs to launch Silence the Sounds of Pertussis Campaign
3. Video: Actress and New Mom Keri Russell Joins PKIDs to Launch Silence the Sounds of Pertussis Campaign
4. Actress and Mother Jennifer Garner Joins American Lung Association to Encourage Americans to Get an Influenza Vaccination
5. MedicAlert Foundation Joins The Alzheimers Association to Offer MedicAlert(R) + Alzheimers Association Safe Return(R) - Live 24-Hour Emergency Response for Wandering and Medical Emergencies
6. Olympic Gold Medalist Kristi Yamaguchi Joins American Lung Association of Michigan to Address Seriously Low Vaccination Rates; Urge Metro-Detroiters to Get Immunized This Season
7. William R. Ringo Joins Hyperion Therapeutics, Inc. Board of Directors as Chairman
8. Dr. Rajeev Venkayya Joins Gates Foundation as Director of Global Health Delivery
9. Dr. Harriet Robinson Joins GeoVax Team as V.P. of R & D to Accelerate AIDS Vaccine Trials Program
10. Dr. Peter Nash, Ph.D. Joins Mach One Corporation as Chief Scientist
11. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... Incretin Mimetics/GLP-1 Agonists, SNDRIs, Lipase Inhibitors, Serotonin Receptor Agonists, Sympathomimetic-GABA Receptor ... market is expected to grow at a CAGR of 27.1% ... 38.7% in the second half of the forecast period. The market ... to 2027. The market is estimated at $1,058 million in 2016, ... ...
(Date:1/19/2017)... RATON, Fla. , Jan. 19, 2017 /PRNewswire/ ... a medical device company specializing in the treatment ... such as keloids, with superficial radiation therapy, today ... and full year 2016 financial results on Thursday, February ... The Company will hold a conference call with ...
(Date:1/19/2017)... January 19, 2017 New ... to Address Motor Symptoms and Motor Complications in ... ...      (Logo: http://photos.prnewswire.com/prnh/20151014/276718LOGO) C ... European Neurological Review,2016;11(Suppl. 2): 2-15, http://www.touchneurology.com/articles/safinamide-new-therapeutic-option-address-motor-symptoms-and-motor-complications-mid-late ...
Breaking Medicine Technology:
(Date:1/19/2017)... ... January 19, 2017 , ... LabRoots ... scientists from around the world, announces the launch of its newly redesigned website. ... portal to research breakthroughs and trending news, vital information on upcoming virtual events ...
(Date:1/19/2017)... ... , ... Cosmetic Town, an online plastic surgery community, begins 2017 with an ... for their readers to get the information they desire. The procedures are now listed ... used on those particular areas. , “We are excited to streamline our listings in ...
(Date:1/19/2017)... NJ (PRWEB) , ... January 19, 2017 , ... ... certified dermatologist by the American Board of Dermatology and fellowship trained Mohs and ... the National Institutes of Health, Dr. Li completed his internship in internal medicine ...
(Date:1/19/2017)... ... January 19, 2017 , ... ... doctor who administered fillers that resulted in severe facial disfiguration. After four frightening ... on by doctors at UCLA Medical Center, who removed the substances in a ...
(Date:1/19/2017)... , ... January 19, 2017 , ... ... and privacy panel system. , The Tranquility privacy panel system was designed ... office environment. Tranquility panels help reduce noise and provide the visual privacy required ...
Breaking Medicine News(10 mins):